4
Changes in Ownership
RELMADA THERAPEUTICS, INC. Filed Acc 0001213900-21-014656
CFO sold 10,000 shares at an average $35.45 ($354,507)
- CFO acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shenouda Maged · CFO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-08 | Exercise or conversion : show line 1 in the form | +10,000 | $3.24 | $32,400 | 12,228 | D |
| 2021-03-08 | Sale : show line 2 in the form | −100 | $35.00 | $3,500 | 12,128 | D |
| 2021-03-09 | Sale : show line 3 in the form | −5,727 | $35.42 | $202,857 | 6,401 | D |
| 2021-03-09 | Sale : show line 4 in the form | −1,800 | $36.02 | $64,836 | 4,601 | D |
| 2021-03-10 | Sale : show line 5 in the form | −2,373 | $35.11 | $83,313 | 2,228 | D |
| Open-market sales · 10,000 sh · avg $35.45 · $354,507 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-08 | Exercise or conversion : show line 6 in the form Options to purchase common stock | −10,000 | 70,350 | D |
Loading xslF345X03/ownership.xml…